GLIVEC

This brand name is authorized in Austria, Australia, Brazil, Cyprus, Germany, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Mexico, Nigeria, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom

Active ingredients

The drug GLIVEC contains one active pharmaceutical ingredient (API):

1 Imatinib UNII 8A1O1M485B - IMATINIB MESYLATE

Imatinib is a protein-tyrosine kinase inhibitor which potently inhibits the Bcr-Abl tyrosine kinase at the in vitro, cellular and in vivo levels. Read about Imatinib

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
GILVEC Film-coated tablet	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L01EA01	Imatinib	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01E Protein kinase inhibitors → L01EA BCR-ABL tyrosine kinase inhibitors
Discover more medicines within L01EA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 11752M, 11753N, 11758W, 11762C, 11765F, 11769K, 11775R, 11778X, 11780B, 11781C, 11784F, 11785G, 11786H, 11787J, 11788K, 11789L, 11878E, 11880G, 5443L, 5444M, 9111M, 9112N, 9113P, 9114Q, 9115R, 9116T, 9123E, 9124F, 9172R, 9173T, 9174W, 9175X, 9176Y, 9177B, 9178C, 9179D
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 526507102113210, 526507103111211
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 00189109, 00491943, 01685603, 01755166, 01755195, 01755203, 01810988, 02759574, 03560892, 04980248, 05497815, 05558801, 06140127, 06140133, 06846353, 08599321, 08880791, 09743926, 10843745, 11126856, 11606473, 12726305, 13167339, 13331862, 13781909, 13824978, 13889624, 14385038, 15786644, 16151221, 16151238, 16808017, 16808023, 17602329
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 23.892-1-06-11, 25.438-11-03
Country: EE	Ravimiamet	Identifier(s): 1085677, 1085688, 1085699, 1085701, 1085712, 1085723, 1209798, 1209800, 1209811, 1209822, 1209833, 1209844, 1209855
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 01198008, 01198010
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 085826
Country: FR	Base de données publique des médicaments	Identifier(s): 63485353, 64936439
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 73199, 80897
Country: HK	Department of Health Drug Office	Identifier(s): 49431
Country: IE	Health Products Regulatory Authority	Identifier(s): 88550, 88581
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 4854, 4855
Country: IT	Agenzia del Farmaco	Identifier(s): 035372059
Country: JP	医薬品医療機器総合機構	Identifier(s): 4291011F1028
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1007379, 1008767, 1028663, 1028664, 1028665, 1028666, 1028667, 1028668, 1028669, 1028670, 1028671, 1028672, 1028673, 1056526, 1088010, 1088011, 1088012
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 498M2003
Country: NG	Registered Drug Product Database	Identifier(s): A4-9056
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 60097, 71293, 71307
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 11140, 11141
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100080415, 100080591, 100105262, 100105279
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W64766001, W64766002, W64766003, W64766004, W64766005
Country: SG	Health Sciences Authority	Identifier(s): 13279P, 13280P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699504093063, 8699504093070